>> Follow the money. Is there a financial incentive? <<
Actually no. You’re thinking to get people on monoclonal antibodies who don’t need them? Require endless, unnecessary tracing? Not under current policies, but if Pfizer’s and Merck’s drugs were fully on the market, I could see it.
Financial incentives are from govt to hospitals...